TY - JOUR
T1 - Merging Our Understanding of Anxiety and Exposure
T2 - Using Inhibitory Learning to Target Anxiety Sensitivity in Exposure Therapy
AU - Bautista, Chandra L.
AU - Teng, Ellen J.
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This material is based upon work supported in part by the Department of Veterans Affairs, the VA HSR&D Houston Center for Innovations in Quality, Effectiveness and Safety (CIN13-413), and the Center for Innovative Treatment of Anxiety and Stress (CITRAS) of the Mental Health Care Line at the Michael E. DeBakey VA Medical Center. The views expressed in this article are those of the author(s) and do not necessarily reflect the views, position, or policy of the Department of Veterans Affairs, the South Central MIRECC, or the United States government.
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This material is based upon work supported in part by the Department of Veterans Affairs, the VA HSR&D Houston Center for Innovations in Quality, Effectiveness and Safety (CIN13-413), and the Center for Innovative Treatment of Anxiety and Stress (CITRAS) of the Mental Health Care Line at the Michael E. DeBakey VA Medical Center. The views expressed in this article are those of the author(s) and do not necessarily reflect the views, position, or policy of the Department of Veterans Affairs, the South Central MIRECC, or the United States government.
Publisher Copyright:
© The Author(s) 2021.
PY - 2022/7
Y1 - 2022/7
N2 - Exposure-based therapies are the gold standard treatment for anxiety disorders, and recent advancements in basic and clinical research point to the need to update the implementation of exposure. Recent research has highlighted the importance of transdiagnostic factors such as anxiety sensitivity (AS), or fear of anxiety-related sensations. Elevated AS is common among all anxiety disorders and contains three dimensions, or expectancies, that can be used to guide treatment. Recently, treatments directly targeting AS have shown potential in reducing symptoms of anxiety. In addition, inhibitory learning theory (ILT) provides an alternative explanation of exposure processes based on basic learning research. ILT extends the current framework by accounting for renewal of fear, which is important given the substantial number of individuals who experience a return of symptoms following treatment. The current paper will provide an overview of ILT and discuss several ILT techniques that can be used to target AS. These two converging bodies of research hold strong potential for optimizing treatment for anxiety.
AB - Exposure-based therapies are the gold standard treatment for anxiety disorders, and recent advancements in basic and clinical research point to the need to update the implementation of exposure. Recent research has highlighted the importance of transdiagnostic factors such as anxiety sensitivity (AS), or fear of anxiety-related sensations. Elevated AS is common among all anxiety disorders and contains three dimensions, or expectancies, that can be used to guide treatment. Recently, treatments directly targeting AS have shown potential in reducing symptoms of anxiety. In addition, inhibitory learning theory (ILT) provides an alternative explanation of exposure processes based on basic learning research. ILT extends the current framework by accounting for renewal of fear, which is important given the substantial number of individuals who experience a return of symptoms following treatment. The current paper will provide an overview of ILT and discuss several ILT techniques that can be used to target AS. These two converging bodies of research hold strong potential for optimizing treatment for anxiety.
KW - anxiety
KW - behavior
KW - transdiagnostic
UR - http://www.scopus.com/inward/record.url?scp=85104045656&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104045656&partnerID=8YFLogxK
U2 - 10.1177/01454455211005073
DO - 10.1177/01454455211005073
M3 - Article
C2 - 33825494
AN - SCOPUS:85104045656
SN - 0145-4455
VL - 46
SP - 819
EP - 833
JO - Behavior Modification
JF - Behavior Modification
IS - 4
ER -